Cargando…

Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

BACKGROUND: Previous studies demonstrate a reduced risk of thrombosis and mortality with anticoagulant treatment in patients with COVID-19 than in those without anticoagulation treatment. However, an open question regarding the efficacy and safety of therapeutic anticoagulation (T-AC) versus a lower...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duo, Hong, Li, Yahui, Sun, Yujie, Wei, Liang, Wang, Ziqing, Fang, Fang, Zhong, Yuxin, Huang, Jiao, Luo, Linjie, Peng, Zhiyong, Pan, Huaqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395810/ https://www.ncbi.nlm.nih.gov/pubmed/35999599 http://dx.doi.org/10.1186/s12959-022-00408-9

Ejemplares similares

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
por: Zhang, Sirui, et al.
Publicado: (2021)

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2022)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Rauniyar, Robin, et al.
Publicado: (2022)

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
por: Zhang, Guqin, et al.
Publicado: (2020)

Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
por: Lee, Hyeon-Jeong, et al.
Publicado: (2023)

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2020)

Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
por: Dewulf, B, et al.
Publicado: (2013)

EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
por: FAIZAN, UNAIZA, et al.
Publicado: (2022)

Prophylactic anticoagulation for patients in hospital with covid-19
Publicado: (2021)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants
por: Guo, Mingyue, et al.
Publicado: (2022)

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis
por: Scheier, Thomas C, et al.
Publicado: (2023)

Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis
por: Hasan, Syed Shahzad, et al.
Publicado: (2020)

EVALUATION OF THERAPEUTIC VS PROPHYLACTIC ANTICOAGULATION IN NONCRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: GHOSH, KULDEEP, et al.
Publicado: (2022)

Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
por: Aghamohammadi, Mehdi, et al.
Publicado: (2020)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
por: Jiao, Jing, et al.
Publicado: (2023)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
por: Zhou, Ya, et al.
Publicado: (2021)

Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study
por: Mina, Jonathan, et al.
Publicado: (2023)

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
por: Lopes, Renato D, et al.
Publicado: (2021)

Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis
por: Shrestha, Dhan B., et al.
Publicado: (2023)

Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis
por: Qin, Xie, et al.
Publicado: (2015)

Prophylactic Intra-Peritoneal Drainage After Pancreatic Resection: An Updated Meta-Analysis
por: Liu, Xinxin, et al.
Publicado: (2021)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
por: Fischer, Hendrik S., et al.
Publicado: (2021)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Surgical Site Infections and Other Postoperative Complications following Prophylactic Anticoagulation in Total Joint Arthroplasty
por: Wang, Zhong, et al.
Publicado: (2014)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis
por: Liao, Zheng, et al.
Publicado: (2023)

The Comparison of Therapeutic With Prophylactic Anticoagulation on Mortality, Risk of Bleeding, and Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review
por: Kham, Nang I, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l981d1vosd7b16k24fuuo8go45